Pure proton therapy for skull base chordomas and chondrosarcomas: A systematic review of clinical experience
Authors:
Open Access
- 25 November 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 12, 1016857
Abstract
Background: Skull base chordoma and chondrosarcoma are exceptionally rare bone tumors with high propensity for local recurrence. Different postoperative radiation modalities are often used to improve the clinical efficacy. Proton therapy (PT) might be among the most promising ones because of the unique ballistic characteristics of high-energy particles. However, previous meta-analysis often included studies with combined radiation techniques. No systematic review to date has directly analyzed the survival and toxicity of pure PT for these two types of malignancies.Methods: By following the PRISMA guidelines, a systematic search of three databases was conducted. Articles were screened and data were extracted according to a prespecified scheme. R 4.2.0 software was used to conduct the meta-analysis. Normal distribution test was used for the incidence rate of each subgroup.Results: A total of seven studies involving 478 patients were included in this analysis. The quality of included articles ranged from moderate to high quality. All patients were histopathologically diagnosed with chordoma or chondrosarcoma, and the follow-up time of the cohort ranged from 21 to 61.7 months. For PT planning, the median target volume ranged from 15 cc to 40 cc, and the administered median dose varied from 63 to 78.4 GyRBE at 1.8–2.0 GyRBE per fraction. The 1-, 2-, 3-, 5-, and 7-year local control and overall survival rates were 100%, 93%, 87%, 78%, and 68%, and 100%, 99%, 89%, 85%, and 68%, respectively. The late grade 3 or higher toxicities were reported in only two involved articles.Conclusions: Until now, medical centers worldwide have exerted PT to improve outcomes of skull base chordomas and chondrosarcomas. PT not combined with other radiation modalities showed favorable local control and survival with a low incidence of severe radiation-induced toxicities, which manifests promising clinical benefits. However, high-quality evidence is still limited, requiring future clinical trials and prospective studies in selected patients.Keywords
This publication has 48 references indexed in Scilit:
- Proton Therapy for Skull Base Chordomas: An Outcome Study from the University of Florida Proton Therapy InstituteJournal of Neurological Surgery Part B: Skull Base, 2013
- Current comprehensive management of cranial base chordomas: 10-year meta-analysis of observational studiesJournal of Neurosurgery, 2011
- Feasibility of Proton Beam Therapy for Chordoma and Chondrosarcoma of the Skull BaseJournal of Neurological Surgery Part B: Skull Base, 2011
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010
- Charged particles in radiation oncologyNature Reviews Clinical Oncology, 2009
- Current Clinical Evidence for Proton TherapyThe Cancer Journal, 2009
- Cranial base chordoma – long term outcome and review of the literatureActa Neurochirurgica, 2008
- A Treatment Planning Comparison of Combined Photon–Proton Beams Versus Proton Beams–Only for the Treatment of Skull Base TumorsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Skull base chordomaHead & Neck, 2005
- Proton radiation therapy for chordomas and chondrosarcomas of the skull baseJournal of Neurosurgery, 1999